-+ 0.00%
-+ 0.00%
-+ 0.00%

*Heron Therapeutics Raises FY25 Adjusted EBITDA Guidance to $4 M - $12M >HRTX

Dow Jones·05/06/2025 11:47:00

Please log in to view news